Galal Elgemeie | Medicinal Chemistry | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Dr. Galal Elgemeie | Medicinal Chemistry | Best Researcher Award

Helwan University | Egypt

Prof. Elgemeie stands as a distinguished figure in the field of organic and medicinal chemistry, with a research career deeply rooted in the development and mechanistic understanding of organic reactions and their applications in synthesizing antimetabolic agents. His scholarly pursuits bridge fundamental chemistry with biomedical innovation, particularly in the discovery of novel therapeutic compounds aimed at combating cancer and viral diseases. Through his extensive academic contributions, he has established a legacy of excellence that continues to inspire scientists and researchers globally.An internationally recognized scientist, Prof. Elgemeie was elected as a member of the Scientific Board of the International Basic Sciences Programme (IBSP) under UNESCO in Paris, France, reflecting his global influence and leadership in advancing the chemical sciences. His postdoctoral experiences across Germany, the United States, and England—supported by prestigious foundations such as the Alexander von Humboldt Foundation, the Fulbright Program, and the British Council—shaped his multidisciplinary expertise and broadened his research collaborations across continents.Prof. Elgemeie’s innovative research has led to numerous impactful projects, including the design and synthesis of novel epigenetic small molecules and antimetabolites in collaboration with the Institute of Medicinal Chemistry, Düsseldorf University. His pioneering work in developing sofosbuvir analogues for treating hepatitis C virus (HCV) and hepatocellular carcinoma among Egyptian patients demonstrates his commitment to translating scientific discovery into therapeutic applications with real-world benefits.His publication record is exceptional, with over 270 papers indexed in international databases such as Scopus, and his scientific influence is further underscored by a significant citation index. He has authored influential scientific books with leading publishers like Elsevier, offering comprehensive insights into cancer metabolism and heterocyclic chemistry. Prof. Elgemeie also holds several patents in process, reflecting his drive to innovate beyond academia and contribute to industry-based advancements in medicinal chemistry.Serving as an editorial board member for prominent journals including Current Microwave Chemistry, he continues to guide the global scientific dialogue in his field. His collaborations span several institutions worldwide, reinforcing his reputation as a bridge between Egyptian and international research communities.Beyond research, Prof. Elgemeie has played a vital role in educational reform and academic development across Egypt and the Arab region. He has supervised multiple cooperative projects with the European Community under the TEMPUS programme, contributing to the restructuring of higher education and aligning it with international standards. These initiatives have significantly advanced institutional capacity and innovation within Mediterranean and Arab universities.

Profile: Orcid

Featured Publications

Azzam, R. A., Seif, M. M., El-Demellawy, M. A., & Elgemeie, G. H. (2025). Novel 2-substituted benzothiazole derivatives: Synthesis, in vitro and in silico evaluations as potential anticancer agents. RSC Advances.

Elgemeie, G. H., Fathy, N. M., & Shaarawi, S. I. (2024). Naphthyl cyanoketene N, S-acetals in glycoside synthesis: A new preparative route to a new class of N-naphthylcyanoacrylamide thioglycosides and their conversions to naphthyl–pyrazole hybrids. Nucleosides, Nucleotides & Nucleic Acids.

Abu-Zaied, M. A., Nawwar, G. A., & Elgemeie, G. H. (2024). Novel synthesis of a new class of substituted S-glycosylisothiourea derivatives and their conversion to 5-amino-1,2,4-triazoles. Synthetic Communications.

Metwally, N. H., Elgemeie, G. H., & Fahmy, F. G. (2023). Synthesis and biological evaluation of benzothiazolyl-pyridine hybrids as new antiviral agents against H5N1 bird flu and SARS-CoV-2 viruses. ACS Omega.

Abdallah, A. E. M., Abdel-Latif, S. A., & Elgemeie, G. H. (2023). Novel fluorescent benzothiazolyl-coumarin hybrids as anti-SARS-COVID-2 agents supported by molecular docking studies: Design, synthesis, X-ray crystal structures, DFT, and TD-DFT/PCM calculations. ACS Omega.

Ahmed, E. A., Elgemeie, G. H., & Azzam, R. A. (2023). Synthesis of new sulfapyrimidine and pyrazolo[1,5-a]pyrimidine derivatives. Synthetic Communications.

Khedr, M. A., Zaghary, W. A., Elsherif, G. E., Azzam, R. A., & Elgemeie, G. H. (2023). Purine analogs: Synthesis, evaluation and molecular dynamics of pyrazolopyrimidines-based benzothiazole as anticancer and antimicrobial CDK inhibitors. Nucleosides, Nucleotides & Nucleic Acids.

Karanvir Singh | Medicinal Chemistry | Best Researcher Award

Published on by Top Pharmaceutical

Mr. Karanvir Singh | Medicinal Chemistry | India

Guru Nanak Dev University | India

Mr. Karanvir Singh is a dynamic and highly skilled researcher in the field of pharmaceutical chemistry, currently pursuing his Doctorate of Philosophy at the Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, India. His ongoing doctoral research, under the supervision of Prof. Dr. Preet Mohinder Singh Bedi, focuses on the design and synthesis of 1,2,4-triazine hybrids with Nipecotic acid for anticonvulsant activity, emphasizing computational modeling, synthesis, and biological evaluation of novel anticonvulsant agents. He holds a Master’s degree in Pharmacy (Pharmaceutical Chemistry) from ISF College of Pharmacy, Moga, Punjab, where he completed a thesis on the design and synthesis of 1,2,4-triazine derivatives for anticonvulsant activity under the guidance of Dr. Vikramdeep Monga and Dr. Bhupinder Kumar. His strong academic foundation was built upon a Bachelor of Pharmacy from the Laureate Institute of Pharmacy, Himachal Pradesh.With a blend of academic excellence and industrial exposure, Mr. Singh has worked as an Assistant QA Chemist at United Biotech Pvt. Ltd., where he gained extensive experience in pharmaceutical quality assurance. His scientific expertise spans molecular docking, fragment-based drug design, pharmacophore modeling, molecular dynamics simulations, organic synthesis, compound purification, and structural elucidation using analytical tools such as NMR, FT-IR, HPLC, and Mass spectrometry.Mr. Singh has made significant contributions to the scientific community, authoring multiple research and review articles in reputed journals. His notable publications include Design, Synthesis, and Biological Evaluation of Triazole-Linked Lignan–Monoterpenoid-Based Hybrid Molecules as Xanthine Oxidase Inhibitors with Potent In Vivo Efficacy; Design, Synthesis, and Multi-Target Biological Evaluation of 1,2,3-Triazole Linked Indole–Thiazolidinedione Hybrids as Potent α-Glucosidase, α-Amylase, and DPP-4 Inhibitors with Antioxidant Potential; Design, Synthesis, Antibacterial Evaluation, and Molecular Modelling Studies of 1,2,3-Triazole-Linked Coumarin–Vanillin Hybrids as Potential DNA Gyrase and Topoisomerase IV Inhibitors; and Development of Coumarin-Inspired Bifunctional Hybrids as a New Class of Anti-Alzheimer’s Agents with Potent In Vivo Efficacy. His review works, such as Exploring Norfloxacin Analogs in Combating Antimicrobial Resistance: Design, Mechanistic Insights, and Structure–Activity Relationship and Incredible Indolinedione Derivatives Nucleus in the Development of Anti-Diabetic Drugs: Exploring the Mechanistic Studies, Design, and Structure–Activity Relationship, further demonstrate his broad research vision and scientific depth.

Profile: Google Scholar

Featured Publications

Singh, K., Pal, R., Khan, S. A., Kumar, B., & Akhtar, M. J. Insights into the structure–activity relationship of nitrogen-containing heterocyclics for the development of antidepressant compounds: An updated review. Journal of Molecular Structure.

Singh, A., Malhotra, D., Singh, K., Chadha, R., & Bedi, P. M. S. Thiazole derivatives in medicinal chemistry: Recent advancements in synthetic strategies, structure–activity relationship, and pharmacological outcomes. Journal of Molecular Structure.

Singh, A., Singh, K., Sharma, A., Kaur, K., Kaur, K., Chadha, R., & Bedi, P. M. S. Recent developments in synthetic α-glucosidase inhibitors: A comprehensive review with structural and molecular insight. Journal of Molecular Structure.

Pal, R., Singh, K., Khan, S. A., Chawla, P., Kumar, B., & Akhtar, M. J. Reactive metabolites of the anticonvulsant drugs and approaches to minimize the adverse drug reaction. European Journal of Medicinal Chemistry.

Singh, A., Singh, K., Sharma, A., Kaur, K., Chadha, R., & Bedi, P. M. S. Recent advances in antifungal drug development targeting lanosterol 14α-demethylase (CYP51): A comprehensive review with structural and molecular insights. Chemical Biology & Drug Design.

Sonia Kamboj – Pharmaceutical Chemistry – Excellence in Research-1011 

Published on by Top Pharmaceutical

Dr. Sonia Kamboj - Pharmaceutical Chemistry - Excellence in Research 

Ch. Devi Lal College of Pharmacy Jagadhri Haryana - India

Author Profile

Early Academic Pursuits

Dr. Sonia Kamboj's academic journey began with a strong foundation in pharmaceutical sciences, marked by consistent excellence and dedication. She completed her 10th and 10+2 (Medical) from the Haryana Board of School Education with high marks, achieving 74.0% and 79.2%, respectively. These early achievements set the stage for her future academic pursuits.

Dr. Sonia's passion for pharmaceuticals led her to pursue a Bachelor of Pharmacy (B. Pharmacy) at Guru Gobind Singh College of Pharmacy, Yamunanagar, affiliated with Kurukshetra University (KUK). Graduating in July 2011 with a notable 72.7% and a first division, she demonstrated her commitment to the field. Her academic journey continued with a Master of Pharmacy (M. Pharmacy) in Pharmaceutical Analysis from I.S.F College of Pharmacy, Moga, Punjab, affiliated with Punjab Technical University (PTU) Jalandhar. In September 2013, she graduated with distinction, securing a remarkable 79.5% and earning the prestigious gold medal.

Dr. Sonia's academic journey culminated in a PhD in Pharmaceutical Sciences from MM College of Pharmacy, Mullana (MMDU, Mullana). Her PhD thesis, "Synthesis and Biological Evaluation of New Chromane and its Analogues," reflects her deep engagement with pharmaceutical research and her drive to contribute to the scientific community.

Professional Endeavors

Dr. Sonia Kamboj has made significant strides in her professional career, contributing to the field of pharmaceutical sciences both as an educator and a researcher. She began her professional journey as an Associate Professor at Ch. Devi Lal College of Pharmacy (CDLCOP), Bhagwangarh, Jagadhri, Haryana, in August 2013. Over the course of more than a decade, she has accumulated extensive experience, sharing her knowledge and expertise with students and colleagues alike.

In addition to her teaching responsibilities, Sonia has held several administrative positions. She is a member of the Academic Committee at CDLCOP, demonstrating her commitment to academic excellence and curriculum development. Her involvement extends to professional organizations as well, where she is a member of the Association of Pharmaceutical Teachers of India (APTI), the Indian Pharmacy Graduates Association (IPGA), and the Chinese Chemical Society. Moreover, she has served as an external examiner at Pt B.D. Sharma University, Rohtak, further showcasing her expertise in pharmaceutical sciences.

Contributions and Research Focus

Dr. Sonia Kamboj's research contributions are substantial and varied, reflecting her broad interests within pharmaceutical sciences. Her PhD research focused on the synthesis and biological evaluation of new chromane and its analogues, a project that underscores her commitment to advancing pharmaceutical knowledge. Her M.Pharm project involved the analytical method development and validation for the simultaneous estimation of berberine and curcumin in plant extracts and polyherbal formulations, highlighting her proficiency in analytical techniques and her interest in herbal drug standardization.

Sonia has also contributed to quality analysis in pharmaceutical settings. During her time as an M.Pharm student at ISF Analytical Laboratory (ISFAL) in Moga, Punjab, she performed quality analysis of various drugs, demonstrating her practical skills and attention to detail. Her involvement in quality control and quality assurance during her B.Pharm studies, as well as her technical duties at Ranbaxy Laboratories Limited, further highlight her hands-on experience in the pharmaceutical industry.

Her technical proficiency spans a wide range of analytical methods and instrumental skills, including HPLC, HPTLC, UV-Visible Spectrophotometry, and molecular docking. This technical expertise has been instrumental in her research and teaching, allowing her to guide students effectively in these areas.

Accolades and Recognition

Dr. Sonia Kamboj's achievements have been recognized through various awards and accolades. She received a gold medal from PTU Jalandhar for her outstanding performance in her M.Pharm degree. Additionally, she was awarded the Graduate Pharmacy Aptitude Test (GPAT) Scholarship in 2011, supporting her postgraduate studies in pharmaceutical analysis. Her excellence in research has been acknowledged with the first prize in poster presentation at the ABT-sponsored international conference organized by M.M. College of Pharmacy in February 2024.

Impact and Influence on Pharmaceutical Chemistry

Dr. Sonia Kamboj's impact extends beyond her immediate academic and professional environment. As a resource person, she has been invited to speak on topics such as women empowerment and equity, and has addressed audiences at institutions like Guru Gobind Singh College of Pharmacy and Govt. Middle School Rattangarh, Radaur, Haryana. Her role as a reviewer for scientific manuscripts in reputable journals, including Current Medicinal Chemistry and the Arabian Journal for Science and Engineering, further underscores her influence in the scientific community.

The ultimate goal of pharmaceutical chemistry is to develop new medications that improve health outcomes and quality of life for patients. This field plays a critical role in addressing a myriad of health challenges, from infectious diseases to chronic conditions like diabetes and cancer. By exploring the molecular mechanisms of disease and devising novel therapeutic strategies, pharmaceutical chemists contribute significantly to the advancement of medicine. Their work not only leads to the creation of new drugs but also enhances our understanding of how existing drugs work, paving the way for improved formulations and delivery systems. In essence, pharmaceutical chemistry is a cornerstone of modern healthcare, driving innovations that translate scientific discoveries into tangible health benefits.

Legacy and Future Contributions

Looking ahead, Sonia Kamboj aims to continue her contributions to pharmaceutical sciences through ongoing research, teaching, and professional engagement. Her extensive list of publications, patents, and conference presentations reflects her dedication to advancing the field. Her work on the synthesis and evaluation of novel pharmaceutical compounds, as well as her expertise in analytical methods, positions her as a significant contributor to future developments in pharmaceutical research and education.

Sonia's legacy is marked by her commitment to excellence, her dedication to knowledge sharing, and her passion for advancing pharmaceutical sciences. As she continues to explore new frontiers in her research and professional endeavors, she remains a valuable asset to the academic and scientific communities. Her future contributions will undoubtedly continue to impact the field, fostering innovation and inspiring the next generation of pharmaceutical scientists.

Pharmaceutical chemistry is a dynamic field at the intersection of chemistry and pharmacology, dedicated to the design, synthesis, and development of bioactive compounds into safe and effective therapeutic agents. This discipline encompasses a wide range of activities, including the identification of new chemical entities, the optimization of lead compounds, and the formulation of drugs. It integrates principles from organic chemistry, biochemistry, and molecular biology to understand and manipulate the chemical nature of drugs and their interactions with biological systems. Researchers in pharmaceutical chemistry engage in the rigorous process of drug discovery, which involves high-throughput screening, structure-activity relationship (SAR) studies, and computer-aided drug design (CADD) to identify promising candidates for development.

Notable Publication